{"id":"https://openalex.org/W7222993548","doi":"https://doi.org/10.3389/fphar.2026.1786211","title":"Availability of age-stratified evidence for GLP1 receptor agonists and SGLT2 inhibitors: an analysis of European public assessment reports with a focus on older patients","display_name":"Availability of age-stratified evidence for GLP1 receptor agonists and SGLT2 inhibitors: an analysis of European public assessment reports with a focus on older patients","publication_year":2026,"publication_date":"2026-10-20","ids":{"openalex":"https://openalex.org/W7222993548","doi":"https://doi.org/10.3389/fphar.2026.1786211","pmid":"https://pubmed.ncbi.nlm.nih.gov/42978648","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/13727555"},"language":"en","primary_location":{"id":"doi:10.3389/fphar.2026.1786211","doi":"https://doi.org/10.3389/fphar.2026.1786211","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fphar.2026.1786211","pdf_url":"https://www.frontiersin.org/journals/pharmacology/articles/10.3389/fphar.2026.1786211/pdf","source":{"id":"https://openalex.org/S132108250","display_name":"Frontiers in Pharmacology","issn_l":"1663-9812","issn":["1663-9812"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","ki-jl-1","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Pharmacology","raw_type":"journal-article"},"volume":null,"type":"review","is_traditional":true,"indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://www.frontiersin.org/journals/pharmacology/articles/10.3389/fphar.2026.1786211/pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5107489089","display_name":"Svea St\u00fcdemann","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2799318839","display_name":"Universit\u00e4tsmedizin Greifswald","ror":"https://ror.org/025vngs54","country_code":"DE","type":"healthcare","lineage":["https://openalex.org/I2799318839"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Svea St\u00fcdemann","raw_affiliation_strings":["Department of Clinical Pharmacology, Institute of Pharmacology at the Center of Drug Absorption and Transport (C_DAT), University Medicine Greifswald"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Clinical Pharmacology, Institute of Pharmacology at the Center of Drug Absorption and Transport (C_DAT), University Medicine Greifswald","institution_ids":["https://openalex.org/I2799318839"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5080238797","display_name":"Maik Gollasch","orcid":"https://orcid.org/0000-0003-2797-1934","observed_orcids":["https://orcid.org/0000-0003-2797-1934"]},"institutions":[{"id":"https://openalex.org/I2799318839","display_name":"Universit\u00e4tsmedizin Greifswald","ror":"https://ror.org/025vngs54","country_code":"DE","type":"healthcare","lineage":["https://openalex.org/I2799318839"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Maik Gollasch","raw_affiliation_strings":["Department of Internal Medicine and Geriatrics, University Medicine Greifswald"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Internal Medicine and Geriatrics, University Medicine Greifswald","institution_ids":["https://openalex.org/I2799318839"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5090963996","display_name":"Stefan Engeli","orcid":"https://orcid.org/0000-0002-3087-971X","observed_orcids":["https://orcid.org/0000-0002-3087-971X"]},"institutions":[{"id":"https://openalex.org/I2799318839","display_name":"Universit\u00e4tsmedizin Greifswald","ror":"https://ror.org/025vngs54","country_code":"DE","type":"healthcare","lineage":["https://openalex.org/I2799318839"]}],"countries":["DE"],"is_corresponding":true,"raw_author_name":"Stefan Engeli","raw_affiliation_strings":["Department of Clinical Pharmacology, Institute of Pharmacology at the Center of Drug Absorption and Transport (C_DAT), University Medicine Greifswald"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Clinical Pharmacology, Institute of Pharmacology at the Center of Drug Absorption and Transport (C_DAT), University Medicine Greifswald","institution_ids":["https://openalex.org/I2799318839"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5090963996"],"corresponding_institution_ids":["https://openalex.org/I2799318839"],"apc_list":{"value":3150,"currency":"CHF","value_usd":3801},"apc_paid":{"value":3150,"currency":"CHF","value_usd":3801},"fwci":0.0,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":{"value":0.58085734,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"17","issue":null,"first_page":"1786211","last_page":"1786211"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.9839000105857849,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.9839000105857849,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12547","display_name":"Pharmaceutical studies and practices","score":0.007400000002235174,"subfield":{"id":"https://openalex.org/subfields/2735","display_name":"Pediatrics, Perinatology and Child Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10496","display_name":"Pharmaceutical Practices and Patient Outcomes","score":0.0013000000035390258,"subfield":{"id":"https://openalex.org/subfields/2717","display_name":"Geriatrics and Gerontology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/sglt2-inhibitors","display_name":"SGLT2 inhibitors","score":1.0},{"id":"https://openalex.org/keywords/elderly-patients","display_name":"elderly patients","score":0.8790000081062317},{"id":"https://openalex.org/keywords/clinical-trial-representation","display_name":"clinical trial representation","score":0.6269999742507935},{"id":"https://openalex.org/keywords/liraglutide","display_name":"liraglutide","score":0.9039999842643738},{"id":"https://openalex.org/keywords/dulaglutide","display_name":"dulaglutide","score":1.0},{"id":"https://openalex.org/keywords/semaglutide","display_name":"semaglutide","score":1.0},{"id":"https://openalex.org/keywords/tirzepatide","display_name":"tirzepatide","score":1.0},{"id":"https://openalex.org/keywords/dapagliflozin","display_name":"dapagliflozin","score":0.9990000128746033},{"id":"https://openalex.org/keywords/empagliflozin","display_name":"empagliflozin","score":1.0},{"id":"https://openalex.org/keywords/cardiovascular-outcome-trials","display_name":"cardiovascular outcome trials","score":0.6729999780654907},{"id":"https://openalex.org/keywords/chronic-kidney-disease","display_name":"chronic kidney disease","score":0.9850000143051147},{"id":"https://openalex.org/keywords/chronic-heart-failure","display_name":"chronic heart failure","score":0.9259999990463257},{"id":"https://openalex.org/keywords/age-subgroup-analysis","display_name":"age subgroup analysis","score":0.5049999952316284}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8658999800682068},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.7264999747276306},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.5004000067710876},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.44530001282691956},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.3961000144481659},{"id":"https://openalex.org/C2777422806","wikidata":"https://www.wikidata.org/wiki/Q409898","display_name":"Dapagliflozin","level":4,"score":0.39489999413490295},{"id":"https://openalex.org/C2778653478","wikidata":"https://www.wikidata.org/wiki/Q1054718","display_name":"Kidney disease","level":2,"score":0.38440001010894775},{"id":"https://openalex.org/C138816342","wikidata":"https://www.wikidata.org/wiki/Q189603","display_name":"Public health","level":2,"score":0.34470000863075256},{"id":"https://openalex.org/C2992672634","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Drug trial","level":3,"score":0.33799999952316284},{"id":"https://openalex.org/C177713679","wikidata":"https://www.wikidata.org/wiki/Q679690","display_name":"Intensive care medicine","level":1,"score":0.33559998869895935},{"id":"https://openalex.org/C2779473830","wikidata":"https://www.wikidata.org/wiki/Q1540899","display_name":"MEDLINE","level":2,"score":0.33000001311302185},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.3181000053882599},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.3131999969482422},{"id":"https://openalex.org/C2993432071","wikidata":"https://www.wikidata.org/wiki/Q45959","display_name":"Drug reaction","level":3,"score":0.30959999561309814},{"id":"https://openalex.org/C2986834420","wikidata":"https://www.wikidata.org/wiki/Q5932254","display_name":"Age groups","level":2,"score":0.30790001153945923},{"id":"https://openalex.org/C512399662","wikidata":"https://www.wikidata.org/wiki/Q3505712","display_name":"Family medicine","level":1,"score":0.3028999865055084},{"id":"https://openalex.org/C73751289","wikidata":"https://www.wikidata.org/wiki/Q2985397","display_name":"Data monitoring committee","level":3,"score":0.29789999127388},{"id":"https://openalex.org/C187960798","wikidata":"https://www.wikidata.org/wiki/Q7631152","display_name":"Subgroup analysis","level":3,"score":0.2921000123023987},{"id":"https://openalex.org/C74909509","wikidata":"https://www.wikidata.org/wiki/Q10387","display_name":"Gerontology","level":1,"score":0.28870001435279846},{"id":"https://openalex.org/C555293320","wikidata":"https://www.wikidata.org/wiki/Q12206","display_name":"Diabetes mellitus","level":2,"score":0.28220000863075256},{"id":"https://openalex.org/C2777436895","wikidata":"https://www.wikidata.org/wiki/Q2045717","display_name":"Summary of Product Characteristics","level":3,"score":0.27489998936653137},{"id":"https://openalex.org/C12174686","wikidata":"https://www.wikidata.org/wiki/Q1058438","display_name":"Risk assessment","level":2,"score":0.2678000032901764},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.2667999863624573},{"id":"https://openalex.org/C159641895","wikidata":"https://www.wikidata.org/wiki/Q108377937","display_name":"Renal function","level":2,"score":0.2662999927997589},{"id":"https://openalex.org/C23276603","wikidata":"https://www.wikidata.org/wiki/Q158230","display_name":"Pharmacoepidemiology","level":3,"score":0.2644999921321869},{"id":"https://openalex.org/C2910001868","wikidata":"https://www.wikidata.org/wiki/Q458","display_name":"European union","level":2,"score":0.26420000195503235},{"id":"https://openalex.org/C2779328685","wikidata":"https://www.wikidata.org/wiki/Q1475557","display_name":"Patient safety","level":3,"score":0.2599000036716461},{"id":"https://openalex.org/C187212893","wikidata":"https://www.wikidata.org/wiki/Q123028","display_name":"Pediatrics","level":1,"score":0.25920000672340393},{"id":"https://openalex.org/C56995899","wikidata":"https://www.wikidata.org/wiki/Q1126687","display_name":"Focus group","level":2,"score":0.25600001215934753},{"id":"https://openalex.org/C60644358","wikidata":"https://www.wikidata.org/wiki/Q128570","display_name":"Bioinformatics","level":1,"score":0.25600001215934753}],"mesh":[],"locations_count":4,"locations":[{"id":"doi:10.3389/fphar.2026.1786211","doi":"https://doi.org/10.3389/fphar.2026.1786211","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fphar.2026.1786211","pdf_url":"https://www.frontiersin.org/journals/pharmacology/articles/10.3389/fphar.2026.1786211/pdf","source":{"id":"https://openalex.org/S132108250","display_name":"Frontiers in Pharmacology","issn_l":"1663-9812","issn":["1663-9812"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","ki-jl-1","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Pharmacology","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:13727555","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC13727555/","pdf_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC13727555/pdf/fphar-17-1786211.pdf","source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Front Pharmacol","raw_type":"Text"},{"id":"pmid:42978648","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/42978648","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in pharmacology","raw_type":"Journal Article"},{"id":"pmh:oai:doaj.org/article:8a3a159d620e44699515821e729a9e39","doi":null,"is_oa":false,"landing_page_url":"https://doaj.org/article/8a3a159d620e44699515821e729a9e39","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Frontiers in Pharmacology, Vol 17 (2026)","raw_type":"article"}],"best_oa_location":{"id":"doi:10.3389/fphar.2026.1786211","doi":"https://doi.org/10.3389/fphar.2026.1786211","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fphar.2026.1786211","pdf_url":"https://www.frontiersin.org/journals/pharmacology/articles/10.3389/fphar.2026.1786211/pdf","source":{"id":"https://openalex.org/S132108250","display_name":"Frontiers in Pharmacology","issn_l":"1663-9812","issn":["1663-9812"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","ki-jl-1","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Pharmacology","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":1.0,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320320879","display_name":"Deutsche Forschungsgemeinschaft","ror":"https://ror.org/018mejw64"}],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W7222993548.pdf","grobid_xml":"https://content.openalex.org/works/W7222993548.grobid-xml"},"referenced_works_count":142,"referenced_works":["https://openalex.org/W807162506","https://openalex.org/W906438903","https://openalex.org/W1682854201","https://openalex.org/W1714643869","https://openalex.org/W1798757189","https://openalex.org/W1899868128","https://openalex.org/W1953840628","https://openalex.org/W1965832529","https://openalex.org/W1973240292","https://openalex.org/W1981378897","https://openalex.org/W1987538170","https://openalex.org/W1992055007","https://openalex.org/W1998281835","https://openalex.org/W2008443217","https://openalex.org/W2015788437","https://openalex.org/W2030192134","https://openalex.org/W2030546890","https://openalex.org/W2035920774","https://openalex.org/W2051243940","https://openalex.org/W2052503411","https://openalex.org/W2054361323","https://openalex.org/W2054981500","https://openalex.org/W2061883499","https://openalex.org/W2067533175","https://openalex.org/W2071835038","https://openalex.org/W2076506641","https://openalex.org/W2077636750","https://openalex.org/W2080383778","https://openalex.org/W2081510795","https://openalex.org/W2090054860","https://openalex.org/W2098459806","https://openalex.org/W2101344933","https://openalex.org/W2101374656","https://openalex.org/W2104252114","https://openalex.org/W2113367996","https://openalex.org/W2114031829","https://openalex.org/W2114276479","https://openalex.org/W2117505171","https://openalex.org/W2122077393","https://openalex.org/W2123984464","https://openalex.org/W2126862523","https://openalex.org/W2137069992","https://openalex.org/W2137352234","https://openalex.org/W2138173919","https://openalex.org/W2138290933","https://openalex.org/W2146264128","https://openalex.org/W2152413054","https://openalex.org/W2160001758","https://openalex.org/W2160274347","https://openalex.org/W2165556241","https://openalex.org/W2170606300","https://openalex.org/W2171471305","https://openalex.org/W2307508267","https://openalex.org/W2425644022","https://openalex.org/W2519510391","https://openalex.org/W2572398654","https://openalex.org/W2602700371","https://openalex.org/W2604469807","https://openalex.org/W2621101635","https://openalex.org/W2743930068","https://openalex.org/W2774157762","https://openalex.org/W2784318050","https://openalex.org/W2787255324","https://openalex.org/W2801715295","https://openalex.org/W2900413769","https://openalex.org/W2918407168","https://openalex.org/W2922550132","https://openalex.org/W2948370538","https://openalex.org/W2948380809","https://openalex.org/W2948612418","https://openalex.org/W2948622224","https://openalex.org/W2951522032","https://openalex.org/W2974260792","https://openalex.org/W2974621372","https://openalex.org/W2974714926","https://openalex.org/W3017978130","https://openalex.org/W3018053472","https://openalex.org/W3081830235","https://openalex.org/W3088173406","https://openalex.org/W3106424730","https://openalex.org/W3115628228","https://openalex.org/W3119307884","https://openalex.org/W3127371223","https://openalex.org/W3129305070","https://openalex.org/W3133495047","https://openalex.org/W3133746780","https://openalex.org/W3138431202","https://openalex.org/W3177122952","https://openalex.org/W3177393241","https://openalex.org/W3185437491","https://openalex.org/W3191712049","https://openalex.org/W3193297191","https://openalex.org/W3205201678","https://openalex.org/W4205651374","https://openalex.org/W4206445899","https://openalex.org/W4210417346","https://openalex.org/W4210940103","https://openalex.org/W4213427170","https://openalex.org/W4224218205","https://openalex.org/W4280597148","https://openalex.org/W4281934192","https://openalex.org/W4288735703","https://openalex.org/W4288740467","https://openalex.org/W4293354639","https://openalex.org/W4304080455","https://openalex.org/W4308183941","https://openalex.org/W4366239802","https://openalex.org/W4381953497","https://openalex.org/W4382050932","https://openalex.org/W4386154055","https://openalex.org/W4387653463","https://openalex.org/W4388592674","https://openalex.org/W4389555309","https://openalex.org/W4392359058","https://openalex.org/W4393255879","https://openalex.org/W4398781461","https://openalex.org/W4399907994","https://openalex.org/W4400855647","https://openalex.org/W4403382203","https://openalex.org/W4403912607","https://openalex.org/W4408991563","https://openalex.org/W4411401097","https://openalex.org/W4412943707","https://openalex.org/W4413137945","https://openalex.org/W4413475907","https://openalex.org/W4415227110","https://openalex.org/W4415359622","https://openalex.org/W4415542024","https://openalex.org/W4415544617","https://openalex.org/W4415854994","https://openalex.org/W7120208224","https://openalex.org/W7128002711","https://openalex.org/W7128924619","https://openalex.org/W7133358587","https://openalex.org/W7133766554","https://openalex.org/W7135073299","https://openalex.org/W7136757486","https://openalex.org/W7138952893","https://openalex.org/W7139114537","https://openalex.org/W7140141003","https://openalex.org/W7164843359","https://openalex.org/W7164878924"],"related_works":["https://openalex.org/W4408059818","https://openalex.org/W4405323925","https://openalex.org/W3133495047","https://openalex.org/W3138998783","https://openalex.org/W7133766554","https://openalex.org/W7127439640","https://openalex.org/W4306290784","https://openalex.org/W3124074039","https://openalex.org/W4403053291","https://openalex.org/W2077180817"],"abstract_inverted_index":{"Background:":[0],"GLP1":[1],"receptor":[2],"agonists":[3],"and":[4,10,39,57,86,139,144,156,173],"SGLT2":[5],"inhibitors":[6],"are":[7],"widely":[8],"prescribed":[9],"their":[11],"use":[12],"is":[13,235],"increasingly":[14],"frequent":[15],"in":[16,30,135,152,178,195,212],"older":[17,26,131,168,208,233],"patient":[18],"populations.":[19,104],"We":[20],"evaluated":[21],"the":[22,48,58,70,79,83,88,109,196,224],"extent":[23],"to":[24,240],"which":[25],"patients":[27,116,126,159,169,231],"were":[28,119,124,132,148,170,182,192,210],"represented":[29,172],"clinical":[31],"trials":[32,85,155,157,239],"of":[33,61,69,82,108,142,175,204,223,246],"liraglutide,":[34,247],"dulaglutide,":[35,248],"semaglutide,":[36,249],"tirzepatide,":[37,250],"dapagliflozin":[38],"empagliflozin.":[40,253],"Methods:":[41],"To":[42],"identify":[43],"relevant":[44],"trials,":[45,138,214],"we":[46,95],"screened":[47],"respective":[49],"European":[50,59,197],"Public":[51,198],"Assessment":[52,199],"Reports":[53],"(n":[54,64,91],"=":[55,65,92,98],"28)":[56],"Summaries":[60],"Product":[62],"Characteristics":[63],"9)":[66],"for":[67,101,115,230],"each":[68],"six":[71],"approved":[72],"medicines.":[73],"Further":[74],"information":[75],"was":[76],"retrieved":[77],"from":[78,87,237],"original":[80],"publications":[81],"identified":[84,194],"ClinicalTrials.gov":[89],"database":[90],"40).":[93],"Overall,":[94],"analyzed":[96,111],"n":[97],"185":[99],"sources":[100],"106":[102,110],"trial":[103,112,220],"Results:":[105],"For":[106],"46%":[107],"populations,":[113],"data":[114,187],"\u226565":[117],"years":[118,129],"identified.":[120],"Where":[121],"age":[122,147,180,190,209,234],"distributions":[123],"reported,":[125],"aged":[127],"75":[128],"or":[130,164,244,252],"markedly":[133],"underrepresented":[134],"nearly":[136],"all":[137,219],"subgroup":[140],"analyses":[141,174],"efficacy":[143,243],"safety":[145,245],"by":[146],"rarely":[149],"published.":[150],"Especially":[151],"cardiovascular":[153],"outcome":[154],"including":[158],"with":[160,207,232],"chronic":[161,165],"kidney":[162],"disease":[163],"heart":[166],"failure,":[167],"better":[171],"primary":[176],"outcomes":[177],"different":[179,189],"groups":[181,191],"published":[183],"more":[184],"frequently.":[185],"Safety":[186],"on":[188],"mainly":[193],"Reports.":[200],"Whereas":[201],"increasing":[202],"numbers":[203],"adverse":[205],"events":[206],"observed":[211],"several":[213],"this":[215],"increase":[216],"typically":[217],"affected":[218],"arms,":[221],"independent":[222],"drug":[225],"treatment.":[226],"Conclusion:":[227],"Data":[228],"availability":[229],"insufficient":[236],"pivotal":[238],"properly":[241],"describe":[242],"dapagliflozin,":[251]},"counts_by_year":[],"updated_date":"2026-11-07T11:25:07.637180","created_date":"2026-10-21T00:00:00"}